Three Defining the Future research grant recipients presented posters at the AAPP 2024 Annual Meeting in Orlando, Florida! Members of the AAPP Foundation Board of Directors visited grant recipient posters and heard a brief presentation about the project and results. Summaries for each project are included below, and posters can be viewed by clicking each project title link. Congratulations to each grant recipient for successful projects!
Andrew Chantha Hean, PharmD, PGY2 Psychiatric Pharmacy Resident, UC San Diego Health: “Evaluation of pharmacy resident burnout and career satisfaction based on residency staffing model”
Dr. Andrew Hean who is a current PGY2 resident with University of California San Diego Health was a recipient of an AAPP Foundation 2023 Defining the Future Research grant for his ongoing project entitled, “Evaluation of Pharmacy Resident Burnout and Career Satisfaction Based on Residency Staffing Model”. His research team includes Dr. Jamie Kneebusch, Dr. Casey Tiefenthaler, and Dr. Kelly Lee.
The purpose of Dr. Hean’s project was to determine if work burnout measured by Maslach Burnout Inventory for Medical Personnel differed based on a resident’s weekend staffing requirements. Additionally, Dr. Hean’s research observed whether career satisfaction was associated with high or low weekend staffing requirements. Data were collected by surveys sent out to all pharmacy residents in the state of California. Survey respondents were classified into three research arms based on the amount of weekend staffing requirements: (1) no weekend staffing, (2) low intensity staffing, and (2) high intensity staffing.
After analyzing the survey data for residents who reported worsening of burnout symptoms from baseline to 6 months into their residency training, a higher worsening of emotional exhaustion was observed in those who reported low intensity staffing compared to those who reported high intensity staffing. In regards to career satisfaction, the study showed no statistical differences among the three staffing groups.
Paige Dorve-Lewis, PharmD, PGY-2 Psychiatric Pharmacy Resident, UPMC Western Psychiatric Hospital: “Overdose Prevention Strategies in High-Risk Youth Populations; Impact of Pharmacist Intervention and Interprofessional Collaboration”
The study evaluated strategies to address prescription overdose in teenagers in Pennsylvania. The intervention educated providers about drug disposal methods and the investigators utilized funds from the foundation to pay for drug disposal boxes. The investigators evaluated knowledge of drug disposal methods before and after their study and found an overall increase in knowledge about drug disposal methods in their post-survey. This was a PGY2 project that was a follow-up to the PGY1 project which just evaluated overdose rates.
Lusi Zhang, PharmD, MHI, PhD Student, University of Minnesota College of Pharmacy, Department of Experimental and Clinical Pharmacology (ECP): “Establishing a Database to Examine the Real-World Impact of Psychiatric Pharmacogenomic Testing in a Large Health System”
Pharmacogenomics (PGx) offers significant potential to advance precision prescribing. However, integrating PGx data into electronic health records (EHR) and clinical workflows remains challenging. Relevance of testing to current treatments and whether existing PGx results are effectively utilized in real-world clinical settings have not been clarified. Therefore, the objective of this project was to develop an EHR-based research database to determine the real-world impact of psychiatric PGx testing.
A comprehensive search was conducted on a large health system’s EHR data from 2012 to 2023 through the institute’s Best Practices Integrated Informatics Core with data extracted and analyzed within a secure data shelter. PGx-related terms identified test result PDF files. Results were all scanned PDFs requiring manual data extraction. PGx test results were stored as scanned PDFs, requiring informatics approaches for identification in the EHR and manual extraction of genotype results. One in 10 patients evaluated had results potentially impactful for current psychiatric medications highlighting the clinical relevance of testing.